These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 20049399)

  • 21. [Juvenil idiopathic arthritis. Part 1: diagnosis, pathogenesis and clinical manifestations].
    Espada G
    Arch Argent Pediatr; 2009 Oct; 107(5):441-8. PubMed ID: 19809766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcome and prognosis in oligoarticular-onset juvenile idiopathic arthritis.
    Guillaume S; Prieur AM; Coste J; Job-Deslandre C
    Arthritis Rheum; 2000 Aug; 43(8):1858-65. PubMed ID: 10943877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Candidate early predictors for progression to joint damage in systemic juvenile idiopathic arthritis.
    Sandborg C; Holmes TH; Lee T; Biederman K; Bloch DA; Emery H; McCurdy D; Mellins ED
    J Rheumatol; 2006 Nov; 33(11):2322-9. PubMed ID: 16960920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prognostic study of juvenile rheumatoid arthritis. Analysis of 544 cases.
    Laaksonen AL
    Acta Paediatr Scand; 1966; ():1-163. PubMed ID: 5944408
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term outcome and prognostic factors in enthesitis-related arthritis: a case-control study.
    Flatø B; Hoffmann-Vold AM; Reiff A; Førre Ø; Lien G; Vinje O
    Arthritis Rheum; 2006 Nov; 54(11):3573-82. PubMed ID: 17075863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are the number of joints involved or the presence of psoriasis still useful tools to identify homogeneous disease entities in juvenile idiopathic arthritis?
    Martini A
    J Rheumatol; 2003 Sep; 30(9):1900-3. PubMed ID: 12966587
    [No Abstract]   [Full Text] [Related]  

  • 27. Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis.
    Kimura Y; Pinho P; Walco G; Higgins G; Hummell D; Szer I; Henrickson M; Watcher S; Reiff A
    J Rheumatol; 2005 May; 32(5):935-42. PubMed ID: 15868633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors affecting the efficacy of intraarticular corticosteroid injection of knees in juvenile idiopathic arthritis.
    Ravelli A; Manzoni SM; Viola S; Pistorio A; Ruperto N; Martini A
    J Rheumatol; 2001 Sep; 28(9):2100-2. PubMed ID: 11550981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Nonconventional therapy in a case of systemic juvenile rheumatoid arthritis].
    Cocchi P; Calabri G; Salvi G; Cocchi C
    Pediatr Med Chir; 1996; 18(3):319-20. PubMed ID: 8966136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Achievement of a state of inactive disease at least once in the first 5 years predicts better outcome of patients with polyarticular juvenile idiopathic arthritis.
    Magnani A; Pistorio A; Magni-Manzoni S; Falcone A; Lombardini G; Bandeira M; Rossi F; Sala I; Martini A; Ravelli A
    J Rheumatol; 2009 Mar; 36(3):628-34. PubMed ID: 19208600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current perspectives of autologous stem cell transplantation for severe Juvenile Idiopathic Arthritis.
    Wulffraat NM; van Rooijen EM; Tewarie R; Brinkman D; Prakken B; Kuis W
    Autoimmunity; 2008 Dec; 41(8):632-8. PubMed ID: 19117174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Medical treatment of juvenile idiopathic arthritis].
    Horneff G; Augustin S
    Med Monatsschr Pharm; 2008 Sep; 31(9):326-36; quiz 337-8. PubMed ID: 18831464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The early pattern of joint involvement predicts disease progression in children with oligoarticular (pauciarticular) juvenile rheumatoid arthritis.
    Al-Matar MJ; Petty RE; Tucker LB; Malleson PN; Schroeder ML; Cabral DA
    Arthritis Rheum; 2002 Oct; 46(10):2708-15. PubMed ID: 12384930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Guidelines for prescribing and monitoring biologic therapies in juvenile idiopathic arthritis].
    Santos MJ; Fonseca JE; Canhão H; Conde M; José Vieira M; Costa L; Costa M; Salgado M; Melo Gomes JA;
    Acta Reumatol Port; 2007; 32(1):43-7. PubMed ID: 17450764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biologic therapies in juvenile idiopathic arthritis: why and for whom?
    McCann LJ; Woo P
    Acta Reumatol Port; 2007; 32(1):15-26. PubMed ID: 17450761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anakinra for systemic juvenile arthritis: the Rocky Mountain experience.
    Zeft A; Hollister R; LaFleur B; Sampath P; Soep J; McNally B; Kunkel G; Schlesinger M; Bohnsack J
    J Clin Rheumatol; 2009 Jun; 15(4):161-4. PubMed ID: 19363453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis.
    Narváez J; Díaz-Torné C; Juanola X; Geli C; Llobet JM; Nolla JM; Díaz-López C
    Ann Rheum Dis; 2009 Apr; 68(4):607-8. PubMed ID: 19286909
    [No Abstract]   [Full Text] [Related]  

  • 38. Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort.
    Oen K; Malleson PN; Cabral DA; Rosenberg AM; Petty RE; Cheang M
    J Rheumatol; 2002 Sep; 29(9):1989-99. PubMed ID: 12233897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features.
    Singh-Grewal D; Schneider R; Bayer N; Feldman BM
    Arthritis Rheum; 2006 May; 54(5):1595-601. PubMed ID: 16645998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Juvenile rheumatoid arthritis. 29 Sicilian cases].
    Fischer A; Garozzo R; Leonardi S; D'Agata A; Musumeci S
    Minerva Pediatr; 1988 Jun; 40(6):327-32. PubMed ID: 3185432
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.